FDA Inspection 1313212 — Wesley Pharmaceuticals
The FDA completed an inspection of Wesley Pharmaceuticals on Mar 16, 2026 in Orlando, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 16, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Orlando, FL (United States)